GRI Bio, Inc.

GRI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B3 Jun 18, 2024 424B3
424B3 Jun 18, 2024 424B3
8-K Jun 18, 2024 8-K
424B3 Jun 17, 2024 424B3
424B3 Jun 17, 2024 424B3
8-K Jun 14, 2024 8-K
8-K Jun 7, 2024 8-K
424B3 May 31, 2024 424B3
424B3 May 31, 2024 424B3
8-K May 22, 2024 8-K
424B3 May 21, 2024 424B3
424B3 May 21, 2024 424B3
8-K May 20, 2024 8-K
424B5 May 20, 2024 424B5
EFFECT May 16, 2024
424B3 May 14, 2024 424B3
424B3 May 14, 2024 424B3
CORRESP May 14, 2024
UPLOAD May 14, 2024
8-K May 13, 2024 8-K
S-3 May 10, 2024 S-3
10-Q May 10, 2024 10-Q
DEF 14A May 9, 2024 DEF 14A
PRE 14A Apr 29, 2024 PRE 14A
8-K Apr 1, 2024 8-K
← Newer Page 7 of 17 · 401 filings Older →